SOLIGENIX, INC. — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2021-12-09

Reporting Person: SCHABER CHRISTOPHER J (Director, Chairman, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-09	Option (Right to Buy)	$0.78	A	60000	Acquired	2031-12-08	Common Stock (60000)	Direct

Footnotes

F1: The stock option vested immediately as to 15,000 shares and vests as to the remainder at a rate of 3,750 of the shares on each three (3) month anniversary of December 9, 2021.